rs730881722
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000136.3(FANCC):c.1201G>A(p.Gly401Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000136.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCC | NM_000136.3 | c.1201G>A | p.Gly401Arg | missense_variant | Exon 13 of 15 | ENST00000289081.8 | NP_000127.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251464Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135916
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461856Hom.: 0 Cov.: 37 AF XY: 0.00000825 AC XY: 6AN XY: 727222
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 401 of the FANCC protein (p.Gly401Arg). This variant is present in population databases (rs730881722, gnomAD 0.009%). This missense change has been observed in individual(s) with clinical features of FANCC-related conditions (PMID: 15695377, 34106356). This variant is also known as c.1456G>A. ClinVar contains an entry for this variant (Variation ID: 182484). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Fanconi anemia complementation group C Uncertain:1
- -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Also reported as 1456G>A (G401R); Identified in individuals with pancreatic cancer or colorectal polyposis (PMID: 15695377, 34106356); This variant is associated with the following publications: (PMID: 15695377, 34106356, Gordon2000[Book]) -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.G401R variant (also known as c.1201G>A), located in coding exon 12 of the FANCC gene, results from a G to A substitution at nucleotide position 1201. The glycine at codon 401 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been previously identified in 1/421 pancreatic cancer cases and 0/654 controls (Couch FJ et al. Cancer Res., 2005 Jan;65:383-6). This alteration has also been reported in an individual with greater than 10 adenomatous colon polyps (Takao M et al. Int J Clin Oncol, 2021 Sep;26:1661-1670). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at